Siemens Healthineers Opens Innovation Center in Erlangen

Siemens HealthineersSiemens Healthineers has opened its new Innovation Center in Erlangen, Germany, in the heart of the regional medical technology research area known as Medical Valley. The focus is on open innovation by collaborating with external partner companies, start-ups and academic and clinical institutions to improve healthcare worldwide. The innovation center complements an existing ecosystem of centers in Shanghai, China, and Bengaluru, India. The underpinning idea is to create an infrastructure to strengthen innovation across the region, promote open collaboration in research, development and production, and enable customer- and market-oriented development.

"With our new Innovation Center, we are highlighting our commitment to the Erlangen and Forchheim locations and continuing to consistently implement our strategy of an open innovation culture," said Peter Schardt, Chief Technology Officer (CTO) of Siemens Healthineers. "The goal is to jointly focus on new technologies and value-added processes that have the potential to disrupt the healthcare system for the benefit of patients. By promoting open collaborations and projects, Siemens Healthineers and its customers will enable more people around the world to access high-quality medical care - from precise diagnosis to the right therapy."

Among other things, the company’s ASOR community has a co-working space in the new premises to further advance research and development for extended reality applications with internal and external partner companies, and to make digital content more tangible. Specifically, the aim is to test and develop prototypes and to virtually simulate medical technology solutions and applications, for example for training.

The Innovation Center is also home to partnerships such as the digital health innovation platform d.hip, an alliance of industry, university medicine and research organizations which aims to advance the digitization of the healthcare system.

In fiscal 2022 Siemens Healthineers invested around €1.8 billion in research and development and holds around 23,000 technical property rights, including around 15,000 granted patents.

About Siemens Healthineers

Siemens Healthineers AG (listed in Frankfurt, Germany: SHL) pioneers breakthroughs in healthcare. For everyone. Everywhere. As a leading medical technology company headquartered in Erlangen, Germany, Siemens Healthineers and its regional companies are continuously developing their product and service portfolio, with AI-supported applications and digital offerings that play an increasingly important role in the next generation of medical technology. These new applications will enhance the company's foundation in in-vitro diagnostics, image-guided therapy, in-vivo diagnostics, and innovative cancer care. Siemens Healthineers also provides a range of services and solutions to enhance healthcare providers' ability to provide high-quality, efficient care. In fiscal 2022, which ended on September 30, 2022, Siemens Healthineers, which has approximately 69,500 employees worldwide, generated revenue of around €21.7 billion and adjusted EBIT of almost €3.7 billion.

Most Popular Now

Open Medical Works with Moray's Dig…

Open Medical is working with the Digital Health & Care Innovation Centre’s Rural Centre of Excellence on a referral management plan, as part of a research and development scheme to...

Generative AI on Track to Shape the Futu…

Using advanced artificial intelligence (AI), researchers have developed a novel method to make drug development faster and more efficient. In a new paper, Xia Ning, lead author of the study and...

Reorganisation, Consolidation, and Cuts:…

NHS England has been downsized and abolished. Integrated care boards have been told to change function, consolidate, and deliver savings. Trusts are planning big cuts. The Highland Marketing advisory board...

AI Tool Uses Face Photos to Estimate Bio…

Eyes may be the window to the soul, but a person's biological age could be reflected in their facial characteristics. Investigators from Mass General Brigham developed a deep learning algorithm...

Philips Future Health Index 2025 Report …

Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today unveiled its 2025 Future Health Index U.S. report, "Building trust in healthcare AI," spotlighting the state of...

AI Model Improves Delirium Prediction, L…

An artificial intelligence (AI) model improved outcomes in hospitalized patients by quadrupling the rate of detection and treatment of delirium. The model identifies patients at high risk for delirium and...

Personalized Breast Cancer Prevention No…

A new telemedicine service for personalised breast cancer prevention has launched at preventcancer.co.uk. It allows women aged 30 to 75 across the UK to understand their risk of developing breast...

New App may Help Caregivers of People Ge…

A new study by investigators from Mass General Brigham showed that a new app they created can help improve the quality of life for caregivers of patients undergoing bone marrow...

An App to Detect Heart Attacks and Strok…

A potentially lifesaving new smartphone app can help people determine if they are suffering heart attacks or strokes and should seek medical attention, a clinical study suggests. The ECHAS app (Emergency...

A Machine Learning Tool for Diagnosing, …

Scientists aiming to advance cancer diagnostics have developed a machine learning tool that is able to identify metabolism-related molecular profile differences between patients with colorectal cancer and healthy people. The analysis...

Fine-Tuned LLMs Boost Error Detection in…

A type of artificial intelligence (AI) called fine-tuned large language models (LLMs) greatly enhances error detection in radiology reports, according to a new study published in Radiology, a journal of...

DeepSeek-R1 Offers Promising Potential t…

A joint research team from The Hong Kong University of Science and Technology and The Hong Kong University of Science and Technology (Guangzhou) has published a perspective article in MedComm...